Thomas Gad

Insider Reports History

Entity
Individual
Location
C/O Y Mabs Therapeutics, Inc., 230 Park Avenue, 33 Rd Floor, New York, NY
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Gad:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director Common Stock 182K $795K $4.38 Sep 19, 2024 Direct
Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director Common Stock 67.7K $296K $4.38 Sep 19, 2024 By GAD Enterprises LLC
Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director Common Stock 60K $263K $4.38 Sep 19, 2024 By Children
Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director Employee Stock Option (right to buy) 143K Sep 19, 2024 Direct
Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director Employee Stock Option (right to buy) 133K Jan 18, 2024 Direct

Insider Reports Filed by Thomas Gad

Symbol Company Period Transactions Value $ Form Type Date Filed Role
YMAB Y-mAbs Therapeutics, Inc. Sep 19, 2024 2 $100K 4 Sep 20, 2024 CHIEF BUSINESS OFFICER, Director
YMAB Y-mAbs Therapeutics, Inc. Sep 13, 2024 2 -$1.26M 4 Sep 17, 2024 CHIEF BUSINESS OFFICER, Director
YMAB Y-mAbs Therapeutics, Inc. Jun 10, 2024 2 -$841K 4 Jun 11, 2024 CHIEF BUSINESS OFFICER, Director
YMAB Y-mAbs Therapeutics, Inc. May 21, 2024 2 -$396K 4 May 23, 2024 CHIEF BUSINESS OFFICER, Director
YMAB Y-mAbs Therapeutics, Inc. Mar 5, 2024 1 -$64.1K 4 Mar 7, 2024 CHIEF BUSINESS OFFICER, Director
YMAB Y-mAbs Therapeutics, Inc. Jan 18, 2024 2 $0 4 Jan 22, 2024 CHIEF BUSINESS OFFICER, Director
YMAB Y-mAbs Therapeutics, Inc. Dec 21, 2023 2 $100K 4 Dec 26, 2023 Chief Business Officer, Director
YMAB Y-mAbs Therapeutics, Inc. Dec 13, 2023 3 -$1M 4 Dec 15, 2023 Chief Business Officer, Director
YMAB Y-mAbs Therapeutics, Inc. Nov 20, 2023 2 -$795K 4 Nov 22, 2023 Chief Business Officer, Director
YMAB Y-mAbs Therapeutics, Inc. Nov 6, 2023 1 $0 4 Nov 8, 2023 Chief Business Officer, Director
YMAB Y-mAbs Therapeutics, Inc. Jan 17, 2023 2 $0 4 Jan 19, 2023 Founder, President, Interim Chief Executive Officer and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. May 18, 2022 1 $0 4 May 19, 2022 Founder, President Interim Chief Executive Officer and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Feb 7, 2022 3 -$2.02M 4 Feb 9, 2022 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Feb 3, 2022 2 -$1.06M 4 Feb 7, 2022 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Feb 1, 2022 3 -$65.2K 4 Feb 3, 2022 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Jan 24, 2022 2 -$936K 4 Jan 26, 2022 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Jan 20, 2022 3 -$2.03M 4 Jan 24, 2022 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Jan 18, 2022 5 -$837K 4 Jan 20, 2022 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Dec 14, 2021 2 $0 4 Dec 16, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Dec 14, 2021 1 $0 4 Dec 16, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Dec 6, 2021 3 -$901K 4 Dec 8, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Nov 29, 2021 5 -$814K 4 Dec 1, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Nov 23, 2021 3 -$753K 4 Nov 26, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Nov 16, 2021 1 -$77.3K 4 Nov 18, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Oct 29, 2021 1 -$99.3K 4 Nov 1, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Oct 15, 2021 1 -$109K 4 Oct 19, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Sep 30, 2021 1 -$113K 4 Oct 4, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Sep 15, 2021 1 -$135K 4 Sep 17, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Sep 2, 2021 3 -$1.56M 4 Sep 7, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Aug 13, 2021 4 -$851K 4 Aug 17, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Aug 3, 2021 1 -$135K 4 Aug 5, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Jul 20, 2021 1 -$130K 4 Jul 21, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Jul 7, 2021 1 -$127K 4 Jul 8, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Jun 30, 2021 1 -$135K 4 Jul 2, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. Jun 14, 2021 1 -$143K 4 Jun 15, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. May 28, 2021 1 -$148K 4 Jun 1, 2021 Chairman, President and Head of Business Development & Strategy, Director
YMAB Y-mAbs Therapeutics, Inc. May 18, 2021 1 -$136K 4 May 20, 2021 Chairman, President and Head of Business Development & Strategy, Director